MBOT
Microbot Medical Inc.NASDAQHealthcare$2.40+1.27%ClosedMarket Cap: $109.4M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.04
P/S
0.00
EV/EBITDA
-7.36
DCF Value
$0.07
FCF Yield
-12.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-24.4%
ROA
-16.1%
ROIC
-18.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-4.1M | $-3.5M | $-0.05 | — |
| FY 2025 | $0.00 | -Infinity% | $-14.7M | $-13.1M | $-0.29 | — |
| Q3 2025 | $0.00 | -Infinity% | $-3.9M | $-3.6M | $-0.07 | — |
| Q2 2025 | $0.00 | -Infinity% | $-3.7M | $-3.5M | $-0.10 | — |
| Q1 2025 | $0.00 | NaN% | $-3.0M | $-2.6M | $0.01 | — |
| Q4 2024 | $0.00 | -Infinity% | $-3.4M | $-3.4M | $-0.20 | — |
| FY 2024 | $0.00 | -Infinity% | $-11.6M | $-11.4M | $-0.73 | — |
| Q3 2024 | $0.00 | NaN% | $-3.3M | $-3.2M | $-0.20 | — |
| Q2 2024 | $0.00 | NaN% | $-2.5M | $-2.5M | $-0.17 | — |
| Q1 2024 | $0.00 | -Infinity% | $-2.4M | $-2.4M | $-0.17 | — |
| Q4 2023 | $0.00 | -Infinity% | $-2.1M | $-3.2M | $-0.26 | — |
| FY 2023 | $0.00 | -Infinity% | $-9.9M | $-10.7M | $-1.05 | — |